Related Experiment Video
Updated: Jan 30, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles
Angelica Ortiz1, Jun Gui1, Farima Zahedi1
1Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Abstract:
Tumor-derived extracellular vesicles (TEV) "educate" healthy cells to promote metastases. We found that melanoma TEV downregulated type I interferon (IFN) receptor and expression of IFN-inducible cholesterol 25-hydroxylase (CH25H). CH25H produces 25-hydroxycholesterol, which inhibited TEV uptake. Low CH25H levels in leukocytes from melanoma patients correlated with poor prognosis. Mice incapable of downregulating the IFN receptor and Ch25h were resistant to TEV uptake, TEV-induced pre-metastatic niche, and melanoma lung metastases; however, ablation of Ch25h reversed these phenotypes. An anti-hypertensive drug, reserpine, suppressed TEV uptake and disrupted TEV-induced formation of the pre-metastatic niche and melanoma lung metastases. These results suggest the importance of CH25H in defense against education of normal cells by TEV and argue for the use of reserpine in adjuvant melanoma therapy.
Insights
Melanoma tumor vesicles educate healthy cells to spread. Cholesterol 25-hydroxylase (CH25H) inhibits this uptake, and reserpine drug shows promise for melanoma treatment.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Tumor-derived extracellular vesicles (TEVs) promote cancer metastasis by altering healthy cells.
- Melanoma TEVs interfere with the type I interferon (IFN) pathway.
Purpose of the Study:
- To investigate the role of IFN-inducible cholesterol 25-hydroxylase (CH25H) in melanoma metastasis.
- To evaluate the therapeutic potential of targeting CH25H or related pathways.
Main Methods:
- Analyzing TEV interaction with host cells.
- Measuring CH25H expression and its product, 25-hydroxycholesterol.
- Utilizing genetically modified mice and pharmacological interventions (reserpine).
Main Results:
- Melanoma TEVs downregulate the IFN receptor and CH25H expression.
- CH25H-produced 25-hydroxycholesterol inhibits TEV uptake.
- Low CH25H levels in patients correlate with poor melanoma prognosis.
- Mice lacking IFN receptor downregulation and Ch25h were resistant to TEV-induced metastasis.
- Reserpine suppressed TEV uptake and melanoma lung metastasis.
Conclusions:
- CH25H is crucial in defending against TEV-mediated cellular education.
- Reserpine demonstrates potential as an adjuvant therapy for melanoma by disrupting metastasis.
Related Concept Videos
Defenses Against Pathogens and Herbivores
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Base Quantities and Derived Quantities
The International Organization for...
The Extracellular Matrix
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...

